Professor Neal D. Shore: Enzalutamide Enables Early Intensification for High-Risk Biochemical Recurrence in Prostate Cancer
Editor’s Note: Prostate cancer is one of the most common malignancies in men. While prostate-specific antigen (PSA) monitoring remains a cornerstone for the early detection of biochemical recurrence (BCR), advances…









